Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging

Table 2

Baseline parameters of the study cohort.

	Biopsy	n	min.-max. (range)	mean (STD)	Sig. (P); (t-test)	t-test; df
Age(years)	F1-F2	32	23-60	36,41(9,55)	-8,145	57
	F3-F4	27	35-78	58,44(11,24)		F1+F2<F3+F4
Weight(kg)	F1-F2	32	35-108	73,06(18,34)	0,124	57
	F3-F4	27	42-120	72,48(17,46)		F1+F2>F3+F4
Height(cm)	F1-F2	32	152-197	171,87(11,26)	3,015	57
	F3-F4	27	153-182	163,93(8,48)		F1+F2>F3+F4
BMI(kg/m^2)	F1-F2	32	15,1-38,6	24,57(5,29)	-1,617	57
	F3-F4	27	16,4-39,2	26,79(5,23)		F1+F2<F3+F4
Platelets	F1-F2	32	147-341	227,75(61,24)	4,188	57
(x10^9/L)	F3-F4	27	36-294	157,74(67,09)		F1+F2>F3+F4
Albumin	F1-F2	32	42,3-51,1	47,18(2,2)	4,358	30,117
(g/L)	F3-F4	27	27,3-52,2	40,92(7,19)		F1+F2>F3+F4
INR	F1-F2	32	0,9-1,4	1,046(0,1)	-3,29	33,715
	F3-F4	27	0,9-2,0	1,209(0,24)		F1+F2<F3+F4
AFP	F1-F2	32	0,77-17,91	3,64(3,31)	-3,436	34,155
(kIU/L)	F3-F4	27	0,92-34,91	9,08(7,65)		F1+F2<F3+F4

p<0,001, p<0,01, p<0,05, NS: nonsignificant.